help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sawa, R.
Right arrow Articles by Araki, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sawa, R.
Right arrow Articles by Araki, T.
The Journal of Clinical Endocrinology & Metabolism Vol. 82, No. 12 4028-4031
Copyright © 1997 by The Endocrine Society


Original Studies

Fetal Plasma Hypoxanthine Level in Growth-Retarded Fetuses Before Labor1

R. Sawa, Y. Yoneyama, Y. Otsubo, S. Suzuki, K. Kubonoya, G. G. Power and T. Araki

Department of Obstetrics and Gynecology (R.S., Y.Y., Y.O., S.S., K.K., J.A.), Nippon Medical School, Tokyo, 113 Japan; and the Center for Perinatal Biology (G.G.P.), Loma Linda University, Loma Linda, California 92350

Address all correspondence and requests for reprints to: Yoshio Yoneyama, M.D., Nippon Medical School, Department of Obstetrics and Gynecology, 1–1-5, Sendagi, Bunkyo-ku, Tokyo, 113 Japan.

Hypoxanthine is one of the purine nucleotides and is presumed to accumulate during hypoxia and acidemia. It remains uncertain, however, whether plasma hypoxanthine concentration is a useful indicator of fetal asphyxia; and its relationship to other markers of fetal physiologic state is not clearly defined. The aim of this study was to evaluate whether the level of fetal plasma hypoxanthine is correlated with fetal hypoxia and acidosis in growth-retarded fetuses before the onset of labor.

Cordocentesis was performed in 34 growth-retarded fetuses at 31–35 weeks’ gestation for the measurement of umbilical venous plasma concentrations of hypoxanthine, hemoglobin and lactate concentrations, blood gases, and base deficit. Umbilical venous plasma hypoxanthine concentration was found to be increased significantly, in parallel with the degree of acidosis (r = -0.74, P < 0.05) and base deficit (r = -0.41, P < 0.05), but not to bear a significant relationship to the degree of hypoxemia or other measured variables. We conclude that increases in the plasma concentration of hypoxanthine may reflect an impaired physiological state in growth-retarded fetuses before labor.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1997 by The Endocrine Society